RE: Tipped ReNeuron shares: time to buy22 Dec 2022 15:05
Most did not miss this from the Interims:
"FUNDING UPDATE
The Company has been investigating an equity raise with institutional and other investors. Having regard to the unfavourable conditions in small-cap equity markets, the Board has concluded that it will not be possible to complete an equity raise at the current time. As at 30 November 2022, having recently received the R&D tax credit for FY 2022, the Company has cash of £10.0 million, and through deferring certain expenditure on proprietary programmes and other longer term development plans, the cash runway will be extended until at least the start of the fourth calendar quarter of 2023. This is not expected to compromise the Company's ability to sign commercial exosome collaborations which upon completion should extend the runway until at least 2024."
Which is why the share price crashed at the beginning of the month. And, Directors have not seen fit to buy any shares since the news was announced, even though they are 'cheap'.